Averin Capital is a New York-based venture capital firm backing early-stage companies in the United States at the intersection of technology and health. The firm focuses on human health, life sciences, care delivery and health technology, with exposure to AI-enabled care, biotechnology, medical devices, senior care and pharmaceuticals. It emphasizes an operator-led approach and supports founders through a network of physicians, scientists, founders and healthcare executives; portfolio examples include Biolinq, Freenome, Pine Park Health, Hologen AI and CandidPro.